Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2625 of 3173 entries
View as:

A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00797342 Org: User:
Start: 12/31/08 End: 04/30/09 Due: 04/30/10

Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00137449 Org: User:
Start: 09/30/05 End: 04/30/08 Due: 04/30/09

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

Phase: N/A Priority: Normal
NCT ID: NCT01942135 Org: User:
Start: 09/26/13 End: 09/28/22 Due: 09/28/23

Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development

Phase: N/A Priority: Normal
NCT ID: NCT00401232 Org: User:
Start: 08/31/06 End: 12/31/17 Due: 12/31/18

Drug Use Investigation of Somatropin for GHD-ADULTS.

Phase: N/A Priority: Normal
NCT ID: NCT00601419 Org: User:
Start: 03/31/07 End: 12/31/12 Due: 12/31/13

Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03486457 Org: User:
Start: 08/10/18 End: 04/28/21 Due: 04/28/22

PPI And Food Effect Study For PF-06463922 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02569554 Org: User:
Start: 12/31/15 End: 04/30/16 Due: 04/30/17

Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01243151 Org: User:
Start: 02/28/11 End: 10/31/11 Due: 10/31/12

A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT05434091 Org: User:
Start: 08/15/22 End: 03/29/23 Due: 03/29/24

A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01723254 Org: User:
Start: 12/31/12 End: 06/30/15 Due: 06/30/16

Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone.

Phase: N/A Priority: Normal
NCT ID: NCT00136981 Org: User:
Start: 12/31/03 End: 11/30/06 Due: 11/30/07

Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height

Phase: N/A Priority: Normal
NCT ID: NCT00174421 Org: User:
Start: 04/30/01 End: 08/31/05 Due: 08/31/06

A First In Human Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Single Oral Doses Of PF-06372865

Phase: N/A Priority: Normal
NCT ID: NCT01951144 Org: User:
Start: 10/31/13 End: 07/31/14 Due: 07/31/15

PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03284723 Org: User:
Start: 11/01/17 End: 08/31/21 Due: 08/31/22

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00143143 Org: User:
Start: 09/30/01 End: 02/28/06 Due: 02/28/07

A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00977561 Org: User:
Start: 04/30/10 End: 10/31/11 Due: 10/31/12

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT02187055 Org: User:
Start: 08/31/14 End: 12/31/16 Due: 12/31/17

A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01)

Phase: N/A Priority: Normal
NCT ID: NCT01526057 Org: User:
Start: 03/20/12 End: 05/07/14 Due: 05/07/15

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04889495 Org: User:
Start: 05/16/25 End: 08/16/25 Due: 08/16/26

Bioequivalence Study of PF-06651600 Capsules Relative to Tablets and Estimation of Food Effect on Capsules.

Phase: N/A Priority: Normal
NCT ID: NCT04390776 Org: User:
Start: 09/28/20 End: 07/19/21 Due: 07/19/22

A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets.

Phase: N/A Priority: Normal
NCT ID: NCT00857571 Org: User:
Start: 04/30/09 End: 05/31/09 Due: 05/31/10

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00835978 Org: User:
Start: 08/31/09 End: 02/29/16 Due: 02/28/17

Cost Study of Linezolid Versus Vancomycin Among Previously Hospitalized Patients

Phase: N/A Priority: Normal
NCT ID: NCT01363271 Org: User:
Start: 05/31/11 End: 05/31/12 Due: 05/31/13

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01436656 Org: User:
Start: 09/05/11 End: 11/07/22 Due: 11/07/23

Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options

Phase: N/A Priority: Normal
NCT ID: NCT00945555 Org: User:
Start: 06/30/09 End: 10/31/10 Due: 10/31/11